Identification of phosphorylated serine-15 and -82 residues of HSPB1 in 5-fluorouracil-resistant colorectal cancer cells by proteomics

Journal of Proteomics

Volumn 75, Issue 3, 2012, Pages 806-818

  Sakai, Akiko ^a   Otani, Mieko ^b   Miyamoto, Akiko ^a   Yoshida, Hideji ^c   Furuya, Eisuke ^a   Tanigawa, Nobuhiko ^a  

^a Department of Chemistry ^*  (Japan)

^b KOBE GAKUIN UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

5 fluorouracil resistance; Colorectal cancer; HSPB1; Phosphorylation; Proteomics

Indexed keywords

COFILIN 1; FLUOROURACIL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 27; NUCLEOPHOSMIN; PHOSPHOGLYCERATE KINASE; PROTEASOME; PYRUVATE KINASE; SERINE; SMALL INTERFERING RNA; VALOSIN CONTAINING PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; COLORECTAL CANCER; DOWN REGULATION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HSP27 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEOMICS; SERINE; URACIL NUCLEOTIDES;

EID: 84355162082     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.09.023     Document Type: Article

References (35)

1. Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil:mechanisms of action and clinical strategies. Nat Rev Cancer 2003, 3:330-338.
2. Longley D.B., Allen W.L., Johnston P.G. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta 2006, 1766:184-196.
3. Arya R., Mallik M., Lakhotia S.C. Heat shock genes - integrating cell survival and death. J Biosci 2007, 32:595-610.
4. Kostenko S., Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 2009, 66:3289-3307.
5. Murakami Y., Kazuno H., Emura T., Tsujimoto H., Suzuki N., Fukushima M. Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. Int J Oncol 2000, 17:277-283.
6. Carmichael J., De Graff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987, 47:936-942.
7. Otani M., Tabata J., Ueki T., Sano K., Inouye S. Heat-shock-induced proteins from Myxococcus xanthus. J Bacteriol 2001, 183:6282-6287.
8. Bruey J.M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000, 2:645-652.
9. Havasi A., Li Z., Wang Z., Martin J.L., Botla V., Ruchalski K., et al. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem 2008, 283:12305-12313.
10. Guo K., Kang N.X., Li Y., Sun L., Gan L., Cui F.J., et al. Regulation of HSP27 on NF-κB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. BMC Cancer 2009, 9:100.
11. Murata S., Yashiroda H., Tanaka K. Molecular mechanisms of proteasome assembly. Nat Rev Mol Cell Biol 2009, 10:104-115.
12. Arlt A., Bauer I., Schafmayer C., Tepel J., Müerköster S.S., Brosch M., et al. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene 2009, 28:3983-3996.
13. Zhuang H., Jiang W., Cheng W., Qian K., Dong W., Cao L., et al. Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis. Lung Cancer 2010, 68:27-38.
14. Wang Q., Song C., Li C.C. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol 2004, 146:44-57.
15. Braun R.J., Zischka H. Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim Biophys Acta 2008, 1783:1418-1435.
16. Rosenquist M. 14-3-3 proteins in apoptosis. Braz J Med Biol Res 2003, 36:403-408.
17. Masters S.C., Subramanian R.R., Truong A., Yang H., Fujii K., Zhang H., et al. Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans 2002, 30:360-365.
18. Duan Z., Lamendola D.E., Yusuf R.Z., Penson R.T., Preffer F.I., Seiden M.V. Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res 2002, 22:1933-1941.
19. Mazzoni C., Torella M., Petrera A., Palermo V., Falcone C. PGK1, the gene encoding the glycolytic enzyme phosphoglycerate kinase, acts as a multicopy suppressor of apoptotic phenotypes in S. cerevisiae. Yeast 2009, 26:31-37.
20. Klamt F., Zdanov S., Levine R.L., Pariser A., Zhang Y., Zhang B., et al. Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 2009, 11:1241-1246.
21. Gupta V., Bamezai R.N. Human pyruvate kinase M2: a multifunctional protein. Protein Sci 2010, 19:2031-2044.
22. Stetá A., Veress R., Ovádi J., Csermely P., Kéri G., Ullrich A. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res 2007, 67:1602-1608.
23. Chuang D.M., Hough C., Senatorov V.V. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 2005, 45:269-290.
24. Yung B.Y. Oncogenic role of nucleophosmin/B23. Chang Gung Med J 2007, 30:285-293.
25. Park K.S., Han B.G., Lee K.H., Kim D.S., Kim J.M., Jeon H., et al. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Lett 2009, 18:201-207.
26. Hwang I.T., Chung Y.M., Kim J.J., Chung J.S., Kim B.S., Kim H.J., et al. Drug resistance to 5-FU linked to reactive oxygen species modulator 1. Biochem Biophys Res Commun 2007, 359:304-310.
27. Takada M., Otaka M., Takahashi T., Izumi Y., Tamaki K., Shibuya T., et al. Overexpression of a 60-kDa heat shock protein enhances cytoprotective function of small intestinal epithelial cells. Life Sci 2010, 86:499-504.
28. Marchitti S.A., Brocker C., Stagos D., Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008, 4:697-720.
29. Karasawa H., Miura K., Fujibuchi W., Ishida K., Kaneko N., Kinouchi M., et al. Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells. Cancer Sci 2009, 100:903-913.
30. Yang Y.X., Sun X.F., Cheng A.L., Zhang G.Y., Yi H., Sun Y., et al. Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. J Cancer Res Clin Oncol 2009, 135:181-189.
31. Mori-Iwamoto S., Kuramitsu Y., Ryozawa S., Mikuria K., Fujimoto M., Maehara S., et al. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol 2007, 31:1345-1350.
32. Tsuruta M., Nishibori H., Hasegawa H., Ishii Y., Endo T., Kubota T., et al. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Oncol Rep 2008, 20:1165-1172.
33. Paul C., Simon S., Gibert B., Virot S., Manero F., Arrigo A.P. Dynamic processes that reflect anti-apoptotic strategies set up by HspB1 (Hsp27). Exp Cell Res 2010, 316:1535-1552.
34. Barak V., Goike H., Panaretakis K.W., Einarsson R. Clinical utility of cytokeratins as tumor markers. Clin Biochem 2004, 37:529-540.
35. Liao J., Ku N.O., Omary M.B. Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J Biol Chem 1997, 272:17565-17573.